PROM1 and central nervous system cancer: Knockout of SHP-1 in CD133 chimeric antigen receptor (CAR) T-cells significantly enhanced the cytolytic effect on CD133+ glioma cell lines by CAR T-cells and increased secretion of TNF-α, IL-2 and IFN-γ [122].